Dupont Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-49,999
| Closed | -$72.5K | – | 159 |
|
|
2024
Q1 | $72.5K | Hold |
49,999
| – | – | 0.01% | 64 |
|
|
2023
Q4 | $4.37K | Hold |
49,999
| – | – | ﹤0.01% | 77 |
|
|
2023
Q3 | $7.5K | Hold |
49,999
| – | – | ﹤0.01% | 109 |
|
|
2023
Q2 | $4.5K | Hold |
49,999
| – | – | ﹤0.01% | 506 |
|
|
2023
Q1 | $3.28K | Hold |
49,999
| – | – | ﹤0.01% | 624 |
|
|
2022
Q4 | $2.28K | Hold |
49,999
| – | – | ﹤0.01% | 1229 |
|
|
2022
Q3 | $4K | Hold |
49,999
| – | – | ﹤0.01% | 1344 |
|
|
2022
Q2 | $8K | Hold |
49,999
| – | – | ﹤0.01% | 1402 |
|
|
2022
Q1 | $16K | Hold |
49,999
| – | – | ﹤0.01% | 1458 |
|
|
2021
Q4 | $25K | Hold |
49,999
| – | – | ﹤0.01% | 1501 |
|
|
2021
Q3 | $27K | Hold |
49,999
| – | – | ﹤0.01% | 1502 |
|
|
2021
Q2 | $50K | Buy |
+49,999
| New | +$50K | ﹤0.01% | 1469 |
|